Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Non-malignant lymphoid changes in the lung].

S Vezendi1, I Dobrán

  • 1Klinik für Kardiologie und Pulmologie, Medizinischen Universität Debrecen.

Pneumologie (Stuttgart, Germany)
|December 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].

Zeitschrift fur Kardiologie·2000
Same author

[Catheter ablation procedures in supraventricular tachycardia].

Der Internist·1998
Same author

[Simultaneous occurrence of lupus erythematosus and desquamative interstitial alveolitis].

Orvosi hetilap·1990
Same author

[Hematologic changes in sarcoidosis].

Orvosi hetilap·1990
Same author

[Primary malignant fibrous histiocytoma of the lung].

Orvosi hetilap·1989
Same author

Transfer factor therapy of thoracic sarcoidosis.

Allergologia et immunopathologia·1989
Same journal

Pneumologie (Stuttgart, Germany)·2026
Same journal

Aerosol therapy during noninvasive ventilation (NIV) and nasal high-flow therapy (HFT): current technology and consensus-based recommendations.

Pneumologie (Stuttgart, Germany)·2026
Same journal

[Correction: Pharmacotherapy for Tobacco Dependence: Implementation of the Current G-BA Resolution - Erratum: Information from Section E3 of the DGP regarding the G-BA Resolution].

Pneumologie (Stuttgart, Germany)·2026
Same journal

[Pharmacotherapy for Tobacco Dependence: Implementation of the Current G-BA Resolution - Information from Section E3 of the DGP regarding the G-BA Resolution].

Pneumologie (Stuttgart, Germany)·2026
Same journal

[Acute lung failure].

Pneumologie (Stuttgart, Germany)·2026
Same journal

[The internet as a source of information for patients with sarcoidosis].

Pneumologie (Stuttgart, Germany)·2026
See all related articles

This study reports on five cases of lymphoid interstitial pneumonia (LIP) and two pseudolymphoma cases. Most patients showed significant improvement with corticosteroid treatment, highlighting effective management for these non-malignant lung conditions.

Area of Science:

  • Pulmonology
  • Pathology
  • Oncology

Background:

  • Lymphoid interstitial pneumonia (LIP) and pseudolymphoma are rare non-malignant lung conditions.
  • Distinguishing these from malignant lymphomas is crucial for appropriate patient management.

Purpose of the Study:

  • To present and analyze cases of LIP and pseudolymphoma.
  • To discuss the differential diagnosis of these non-malignant lung changes.

Main Methods:

  • Histological examination of lung biopsy specimens for diagnosis.
  • Treatment with corticosteroids, and in one case, corticosteroids plus cytostatics.
  • Telecobalt therapy was administered to one pseudolymphoma patient.

Main Results:

Related Experiment Videos

  • Five cases of LIP were diagnosed (2 male, 3 female, including a 9-year-old girl).
  • Four out of five LIP patients showed significant improvement and symptom resolution with treatment.
  • One pseudolymphoma patient remained alive and well 14 years post-diagnosis with steroid and cytostatic treatment.
  • The other pseudolymphoma patient died 13 years after diagnosis from an unrelated cause.
  • Conclusions:

    • Corticosteroid therapy appears effective for lymphoid interstitial pneumonia.
    • Pseudolymphoma can have a favorable long-term prognosis with appropriate treatment.
    • Accurate histological diagnosis is essential for differentiating these benign conditions from malignant lung diseases.